The hYSK1, a serine/threonine kinase (STK)-25, has been implicated in a variety of cellular functions including cell migration and polarity. We have recently reported that hYSK1 down-regulated the expression and functions of p16, a cell cycle regulatory protein, thereby enhancing migration and growth of cancer cells under hypoxic conditions. In this study, we further investigated the mechanisms underlying downregulation of p16 and anti-migratory function of hYSK1. Our study revealed that p21 is a novel binding partner of hYSK1. Moreover, the interaction between hYSK1 and p21 led to the inhibition of SP-1 transcriptional activity, as revealed by a significant down-regulation of SP-1-mediated transactivation of p16 promoter, and accelerated MMP-2 expression. Conversely, the knock-down of hYSK1 enhanced the p16 promoter activity and protein expression, and diminished MMP-2 transcription and protein levels in hypoxic conditions as compared to control. Taken together, hYSK1 blocks the p21 functions by direct interaction and inhibits the p16 expression and induces MMP-2 expression by its regulations of SP-1 transcriptional activity under the hypoxia conditions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359055 | PMC |
http://dx.doi.org/10.3390/ijms20020310 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!